Moreover, recent findings have shown that NLRP1 could protect against metabolic syndrome [37] as well as colitis-associated tumorigenesis [38], which indicates that NLRP1 possibly acts as a homeostatic factor. Here, NLRP1 is linked to metabolic syndrome.